Name: Jakavi 20mg Tablet
SKU: H1KCK2G6
Price: 42300
Availability: InStock
Rating: 0 (0 reviews)

Jakavi 20mg Tablet

Salt Composition: Ruxolitinib

Manufacturer: NOVARTIS INDIA LTD

0 0 8

MRP

₹ 48,175

Price

₹ 42,300

You Save

₹ 5,875 (12%)

Status

In Stock

SKU

H1KCK2G6

Jakavi 20mg Tablet contains the active ingredient ruxolitinib, an anticancer medication classified as a kinase inhibitor. It is primarily used to treat myelofibrosis, a rare bone marrow cancer that leads to reduced blood cell production. Additionally, it is prescribed for polycythemia vera, a blood cancer where the body produces excessive red blood cells, particularly in patients who do not respond to or cannot tolerate hydroxyurea.

Jakavi is also indicated for the treatment of acute graft-versus-host disease (GVHD) in adults and children aged 12 and older who have not responded to steroid treatments following a bone marrow transplant. It is also used for chronic GVHD in patients aged 12 and above who have been unsuccessfully treated with one or two prior systemic therapies.

Jakavi works by blocking specific signals that promote the growth and multiplication of cancer cells. You should not take this medication if you are allergic to ruxolitinib or any of its components. Inform your doctor if you currently have or previously had tuberculosis, hepatitis B or C, liver disease, or kidney problems. It is also important to notify your physician if you are undergoing dialysis.

Common side effects of Jakavi include dizziness, low blood counts, bruising, bleeding, headache, and swelling in the face or body. Be sure to discuss any concerns or unusual symptoms with your doctor during treatment.